BIOLASE, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023
The Company expects net loss from operations for the fourth quarter of 2023 to be significantly improved compared to the comparable period for the prior year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.148 USD | 0.00% | +6.47% | -86.81% |
1st Jan change | Capi. | |
---|---|---|
-86.81% | 4.92M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |